跳至主要内容
临床试验/NCT03124069
NCT03124069已完成不适用

A Development Study to Evaluate a Nasal Mask for the Treatment of Obstructive Sleep Apnea

Fisher and Paykel Healthcare2 个研究点 分布在 1 个国家目标入组 37 人开始时间: 2017年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
37
试验地点
2
主要终点
Number of Participants Subjective Performance Rating of the Nasal Mask

研究概览

简要总结

This investigation is designed to evaluate the comfort, ease of use and performance of a trial nasal mask for the treatment of Obstructive Sleep Apnea (OSA) in the home environment.

详细描述

The investigation is a prospective, non-randomized, non-blinded study. Up to 45 OSA patients who currently use a nasal or nasal pillows mask will be recruited

This study will involve a baseline (Visit One) data gathering with the participant's PAP therapy and their usual mask. This will be followed by the participants being fitted with the trial nasal mask for use in-home (Visit Two). The participant then will come in to return the mask (Visit Three) and give feedback on their experience using the mask in home in the form of a structured interview during Visit Three. The maximum amount of time the participants will be exposed to the trial mask in-home will be 14 ± 5 days from Visit Two.

The mask and CPAP (if used from the loan research pool) will be returned to the institution at the conclusion of the trial and participant will return to their usual mask and therapy device for the treatment of Obstructive Sleep Apnea.

Neither the investigators nor the participants will be blinded to the study.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • AHI ≥ 5 from diagnostic PSG night
  • Aged 22 and over (FDA defined as adult)
  • Either prescribed APAP, CPAP or Bi-Level PAP for OSA
  • Existing nasal or nasal pillows mask users (preferable 70%:30% split)
  • Fluent in spoken and written English

排除标准

  • Inability to give informed consent
  • Patient intolerant to CPAP therapy
  • Anatomical or physiological conditions making PAP therapy inappropriate
  • Current diagnosis of respiratory disease or CO2 retention
  • Pregnant or think they may be pregnant

结局指标

主要结局

Number of Participants Subjective Performance Rating of the Nasal Mask

时间窗: 14 ± 5 days In-Home

Performance reported from participants questionnaires to evaluate the use of the F\&P nasal mask for treatment of Obstructive Sleep Apnea

Number of Participants Subjective Reporting of Nasal Mask Usability

时间窗: During Visit Two - 20 minutes

Usability reported from participants questionnaires to evaluate the use of the F\&P nasal mask for treatment of Obstructive Sleep Apnea

Number of Participants Reporting Comfort Compared to Their Usual Mask.

时间窗: 14 ± 5 days In-Home

Comfort reported from participants questionnaires to evaluate the use of the F\&P nasal mask for treatment of Obstructive Sleep Apnea

Number of Participants PAP Device Performance Reporting

时间窗: 14 ± 5 days In-Home

Determined from data recorded from the PAP device to evaluate the use of the F\&P nasal mask for treatment of Obstructive Sleep Apnea

Number of Participants Subjective Recording of Ease of Nasal Mask Use.

时间窗: 14 ± 5 days In-Home

Ease of use reported from participants questionnaires to evaluate the use of the F\&P nasal mask for treatment of Obstructive Sleep Apnea

次要结局

  • Number of Participants Leak Compared to Usual Mask(14 ± 5 days In-Home)
  • Number of Participants With Correct Nasal Mask Size Determination(1 day-time appointment (1 hour))

研究者

发起方
Fisher and Paykel Healthcare
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Development Study to Evaluate a Nasal Mask for the... | 临床试验